1224724-31-5

Basic information

• Product Name: (5-biphenyl-4-yl-6-chloro-1H-benzoimidazol-2-ylsulfanylmethyl)phosphonic acid mono-(3-fluoro-4-methoxybenzyl) ester
• Synonyms: (5-biphenyl-4-yl-6-chloro-1H-benzoimidazol-2-ylsulfanylmethyl)phosphonic acid mono-(3-fluoro-4-methoxybenzyl) ester
• CAS NO: 1224724-31-5
• Molecular Weight: 568.993
• Mol File: 1224724-31-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (5-biphenyl-4-yl-6-chloro-1H-benzoimidazol-2-ylsulfanylmethyl)phosphonic acid mono-(3-fluoro-4-methoxybenzyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: (5-biphenyl-4-yl-6-chloro-1H-benzoimidazol-2-ylsulfanylmethyl)phosphonic acid mono-(3-fluoro-4-methoxybenzyl) ester(1224724-31-5)
• EPA Substance Registry System: (5-biphenyl-4-yl-6-chloro-1H-benzoimidazol-2-ylsulfanylmethyl)phosphonic acid mono-(3-fluoro-4-methoxybenzyl) ester(1224724-31-5)

Safety Data

• Hazardous Substances Data: 1224724-31-5(Hazardous Substances Data)

Upstream product

• 1224724-29-1 (2-(5-biphenyl-4-yl-6-chloro-1H-benzoimidazol-2-ylsulfanyl)methyl)phosphonic acid 
• 96047-32-4 3-fluoro-4-methoxybenzyl alcohol 

Relevant articles and documents

NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS

Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK- activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.